The Seriousness of Meningococcal Disease
Meningococcal disease is a very serious illness caused by a bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Meningococcal disease usually occurs without warning – even among people who are otherwise healthy.
Meningococcal disease can spread from person to person through close contact (coughing or kissing) or lengthy contact, especially among people living in the same household or within a dormitory.
Anyone can get meningococcal disease but certain people are at increased risk, including:
- Infants younger than one year old
- Adolescents and young adults 16 through 23 years old
- People with certain medical conditions that affect the immune system
- Microbiologists who routinely work with isolates of N. meningitidis
- People at risk because of an outbreak in their community
Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, kidney damage, amputations, nervous system problems, or severe scars from skin grafts.
CDC Guidelines Support MenB Vaccinations for 16-Year-Olds
Trumenba: Meningococcal Group B Vaccine
PSG Pharmacy offers the Trumenba Meningococcal Group B Vaccine.
- Trumenba is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.
- The effectiveness of the two-dose schedule of Trumenba against diverse N meningitidis serogroup B stains has not been confirmed.
- Please refer to IMPORTANT SAFETY INFORMATION and additional information about Trumenba at trumenba.com or visit the PSG Pharmacy website at psgrx.net.